Efficacy of Surgical Management of Meralgia Paresthetica
• 2009
Publication Information
Authors
Not Available
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Objective: This study was designed to evaluate the efficacy of surgical decompression in
treatment of meralgia paresthetica. Patients and Methods: This study included 30 patients
(18 females, 12 males) within age range of 24-62 years presented with meralgia paresthetica
with mean duration of symptoms 29.3±5.4 months. All the patients were subjected to
conservative management for 6 months. 12 patients were not improved with conservative
treatment .9 patients (70%) underwent unilateral neurolysis of the lateral femoral cutaneous
nerve (LFCN), whereas 3 patients (25%) underwent bilateral neurolysis of the LFCN.
Surgical outcome was graded subjectively by each patient postoperatively based on 0-5 pain
intensity scale. Results: The mean follow-up period was 14 months; range: 6-24 months.
Surgical outcome was graded subjectively by each patient postoperatively based on 0-5 pain
intensity scale; 5 patients (41.7%) improved completely; 2 patients (16.7%) significant
improved; 1 patient (8.3%) temporary improved; 4 patients (33.3%) not improved, (Table 7).
For the 4 (33.3%) patients who did not improve after surgical decompression, re-exploration
with trans-section of the LFCN was done (1case bilateral, 3 unilateral) & pain improved
completely in all patients. Conclusion: It could be concluded that neurolysis of the LFCN is
an effective treatment for meralgia paresthetica in properly selected patients & trans-section
of the LFCN is indicated for patients who did not improved after surgical decompression.
Keywords: Neurolysis, lateral femoral cutaneous nerve, meralgia paresthetica.
treatment of meralgia paresthetica. Patients and Methods: This study included 30 patients
(18 females, 12 males) within age range of 24-62 years presented with meralgia paresthetica
with mean duration of symptoms 29.3±5.4 months. All the patients were subjected to
conservative management for 6 months. 12 patients were not improved with conservative
treatment .9 patients (70%) underwent unilateral neurolysis of the lateral femoral cutaneous
nerve (LFCN), whereas 3 patients (25%) underwent bilateral neurolysis of the LFCN.
Surgical outcome was graded subjectively by each patient postoperatively based on 0-5 pain
intensity scale. Results: The mean follow-up period was 14 months; range: 6-24 months.
Surgical outcome was graded subjectively by each patient postoperatively based on 0-5 pain
intensity scale; 5 patients (41.7%) improved completely; 2 patients (16.7%) significant
improved; 1 patient (8.3%) temporary improved; 4 patients (33.3%) not improved, (Table 7).
For the 4 (33.3%) patients who did not improve after surgical decompression, re-exploration
with trans-section of the LFCN was done (1case bilateral, 3 unilateral) & pain improved
completely in all patients. Conclusion: It could be concluded that neurolysis of the LFCN is
an effective treatment for meralgia paresthetica in properly selected patients & trans-section
of the LFCN is indicated for patients who did not improved after surgical decompression.
Keywords: Neurolysis, lateral femoral cutaneous nerve, meralgia paresthetica.
Staff Members - Benha University